Literature DB >> 33669238

The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design.

Que Dan Nguyen1, Kosuke Kikuchi1, Basudev Maity1, Takafumi Ueno1.   

Abstract

Protein assemblies provide unique structural features which make them useful as carrier molecules in biomedical and chemical science. Protein assemblies can accommodate a variety of organic, inorganic and biological molecules such as small proteins and peptides and have been used in development of subunit vaccines via display parts of viral pathogens or antigens. Such subunit vaccines are much safer than traditional vaccines based on inactivated pathogens which are more likely to produce side-effects. Therefore, to tackle a pandemic and rapidly produce safer and more effective subunit vaccines based on protein assemblies, it is necessary to understand the basic structural features which drive protein self-assembly and functionalization of portions of pathogens. This review highlights recent developments and future perspectives in production of non-viral protein assemblies with essential structural features of subunit vaccines.

Entities:  

Keywords:  non-viral proteins; protein assemblies; subunit vaccines; vaccine applications; virus-like particles

Mesh:

Substances:

Year:  2021        PMID: 33669238      PMCID: PMC7919822          DOI: 10.3390/ijms22041934

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  109 in total

Review 1.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Authors:  Fakhrul Ahsan; Isabel P Rivas; Mansoor A Khan; Ana I Torres Suarez
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

2.  Stabilization of short collagen-like triple helices by protein engineering.

Authors:  S Frank; R A Kammerer; D Mechling; T Schulthess; R Landwehr; J Bann; Y Guo; A Lustig; H P Bächinger; J Engel
Journal:  J Mol Biol       Date:  2001-05-18       Impact factor: 5.469

3.  Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.

Authors:  Rajesh P Ringe; Anila Yasmeen; Gabriel Ozorowski; Eden P Go; Laura K Pritchard; Miklos Guttman; Thomas A Ketas; Christopher A Cottrell; Ian A Wilson; Rogier W Sanders; Albert Cupo; Max Crispin; Kelly K Lee; Heather Desaire; Andrew B Ward; P J Klasse; John P Moore
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

4.  pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly.

Authors:  Mihee Kim; Yecheol Rho; Kyeong Sik Jin; Byungcheol Ahn; Sungmin Jung; Heesoo Kim; Moonhor Ree
Journal:  Biomacromolecules       Date:  2011-04-08       Impact factor: 6.988

5.  Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response.

Authors:  Rui Zhang; Josiah D Smith; Brittany N Allen; Jake S Kramer; Martin Schauflinger; Bret D Ulery
Journal:  ACS Biomater Sci Eng       Date:  2018-05-21

6.  Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform.

Authors:  Ming Xia; Pengwei Huang; Chen Sun; Ling Han; Frank S Vago; Kunpeng Li; Weiming Zhong; Wen Jiang; John S Klassen; Xi Jiang; Ming Tan
Journal:  ACS Nano       Date:  2018-09-25       Impact factor: 15.881

7.  Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge.

Authors:  Christopher P Karch; Jianping Li; Caroline Kulangara; Sara M Paulillo; Senthil K Raman; Sharareh Emadi; Anmin Tan; Zeinab H Helal; Qing Fan; Mazhar I Khan; Peter Burkhard
Journal:  Nanomedicine       Date:  2016-09-02       Impact factor: 5.307

Review 8.  Applications of viral nanoparticles in medicine.

Authors:  Ibrahim Yildiz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Curr Opin Biotechnol       Date:  2011-05-16       Impact factor: 9.740

Review 9.  Peptide-based synthetic vaccines.

Authors:  Mariusz Skwarczynski; Istvan Toth
Journal:  Chem Sci       Date:  2015-12-17       Impact factor: 9.825

10.  An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.

Authors:  Sebastian Aston-Deaville; Emil Carlsson; Muhammad Saleem; Angela Thistlethwaite; Hannah Chan; Sunil Maharjan; Alessandra Facchetti; Ian M Feavers; C Alistair Siebert; Richard F Collins; Alan Roseman; Jeremy P Derrick
Journal:  Vaccine       Date:  2020-03-13       Impact factor: 3.641

View more
  5 in total

1.  Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.

Authors:  Anna S Karyagina; Alexander V Gromov; Tatyana M Grunina; Alexander M Lyaschuk; Alexander V Grishin; Natalia V Strukova; Maria S Generalova; Zoya M Galushkina; Lyubov' A Soboleva; Olga Yu Dobrinina; Tatyana N Bolshakova; Marina E Subbotina; Ekaterina A Romanovskaya-Romanko; Igor V Krasilnikov; Nikita B Polyakov; Andrey I Solovyev; Daniil A Grumov; Vladimir G Zhukhovitsky; Ekaterina I Ryabova; Vladimir V Prokofiev; Vladimir G Lunin
Journal:  Biochemistry (Mosc)       Date:  2021-10       Impact factor: 2.487

2.  R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice.

Authors:  Xinyu Zhuang; Luer Chen; Songhui Yang; Shengnan Xia; Zhiqiang Xu; Tong Zhang; Boyu Zeng; Tong Yu; Ning Yu; Wei Wang; Huijun Lu; Mingyao Tian; Ningyi Jin
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 3.  Biomimetic and Biological Nanoarchitectonics.

Authors:  Katsuhiko Ariga
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

Review 4.  Nanotechnology-facilitated vaccine development during the coronavirus disease 2019 (COVID-19) pandemic.

Authors:  Wang Ziqi; Cui Kai; Ulrich Costabel; Zhang Xiaoju
Journal:  Exploration (Beijing)       Date:  2022-07-21

Review 5.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.